N-METHOXY-N-METHYLISOXAZOLE-3-CARBOXAMIDE, 95.0%, 250mg

1-((2R,3R,4S,5S)-3,5-DIFLUORO-4-HYDROXY-5-(HYDROXYMETHYL)TETRAHYDROFURAN-2-YL)PYRIMIDINE-2,4(1H,3H)-DIONE, 90.0%, 1g

Lithium 2-(6-(1H-imidazol-1-yl)pyridazine-3-carboxamido)-4,5-difluorobenzoate, 98.0%, 100mg

1,3-Di(thiophen-2-yl)propane-1,3-dione, 97.0%, 5g

Bis(3-aminopropyl) Ether>98.0%(GC)(T)5mL

N1,N1-Diethyl-2-methylbenzene-1,4-diamine hydrochloride, 95.0%, 500g

1,3-Dimethyl-2,4-dioxo-1,2,3,4-tetrahydro-pyrimidine-5-sulfonyl chloride, 95.0%, 1g

2-(2-Tolyl)-4-(2-hydroxyphenyl)thiazole, 1g

(R)-Methyl 2-(benzylamino)-3-hydroxypropanoate, 95.0%, 5g

1-(3-Cyanobenzyl)imidazole, 97.0%, 1g

4-Nitrophthalamide, 95.0%, 100g

2-(2,6-Dioxopiperidin-3-yl)-5-fluoroisoindoline-1,3-dione, 97.0%, 25g

2-Cyclopentylpropanoic acid, 98+%, 250mg